These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6460247)

  • 1. Suppressor cell activity in human renal allograft recipients.
    Hammer C; Land W; Castro LA
    Proc Eur Dial Transplant Assoc; 1981; 18():454-8. PubMed ID: 6460247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor cells in human renal allograft recipients.
    Jayavant M; Braun WE; Novick A
    Transplant Proc; 1979 Dec; 11(4):1838-42. PubMed ID: 161099
    [No Abstract]   [Full Text] [Related]  

  • 3. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
    Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD
    Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine monocytes and macrophages: an accessory role in suppressor-cell generation by Con A and in lectin-induced proliferation.
    Ohmann HB; Filion LG; Babiuk LA
    Immunology; 1983 Oct; 50(2):189-97. PubMed ID: 6225726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of transfusion-induced suppressor cells in prospective kidney allograft recipients.
    Lenhard V; Massen G; Seifert P; Johannsen R; Grosse-Wilde H
    Transplant Proc; 1982 Jun; 14(2):329-32. PubMed ID: 6214060
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.
    Baeten D; Louis S; Braud C; Braudeau C; Ballet C; Moizant F; Pallier A; Giral M; Brouard S; Soulillou JP
    J Am Soc Nephrol; 2006 Jan; 17(1):294-304. PubMed ID: 16338967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro X-ray irradiation of human peripheral blood T lymphocytes enhances suppressor function.
    Ogawa H; Tsunematsu T
    Clin Exp Immunol; 1983 Aug; 53(2):444-50. PubMed ID: 6224611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular target of cyclosporin A action in humans.
    Van Buren CT; Kerman R; Agostino G; Payne W; Flechner S; Kahan BD
    Surgery; 1982 Aug; 92(2):167-74. PubMed ID: 6213052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of suppressor T cells in renal transplant recipients and activation by aminophylline.
    Shohat B; Shapira Z; Joshua H; Servadio C
    Thymus; 1983 Mar; 5(2):67-77. PubMed ID: 6222520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor cells inhibiting the generation of cytotoxic T lymphocytes in long-term human transplant recipients.
    Thomas J; Johns C; Hoffmann S; Thomas F; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():87-9. PubMed ID: 158755
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppressor cells in kidney allograft tolerance.
    Charpentier B; Lang P; Martin B; Fries D
    Proc Eur Dial Transplant Assoc; 1981; 18():486-90. PubMed ID: 6460248
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of suppressor cells after activation of human peripheral blood mononuclear cells with sodium periodate.
    Lomnitzer R; Rabson AR
    Immunology; 1982 Jan; 45(1):7-13. PubMed ID: 6276296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
    Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
    Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancer.
    Berd D; Maguire HC; Mastrangelo MJ
    Cancer Res; 1984 Mar; 44(3):1275-80. PubMed ID: 6229330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A continued evaluation of the experimental conditions of a Con A-induced suppressor test system.
    Davidsen B; Kristensen E
    Acta Pathol Microbiol Immunol Scand C; 1983 Aug; 91(4):283-91. PubMed ID: 6227202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
    Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.